Univariate analysis for DMFS showed that clinical variables such as larger tumor size, positive LN (LN+) involvement, and higher histologic grade were significantly associated with an increased risk of distant metastasis in the HR+/HER2− subtype (Table 2). This evidence concerns the gene ERBB2 and neoplasm.